Panel Discussion: Making Gene Therapies for Common CNS Diseases a Reality
Time: 3:30 pm
day: Day Two Whole
Details:
- Designing gene therapy vectors to effectively target brain regions and cell types on more common diseases like AD, PF and Huntington’s
- Leveraging non-viral vectors to improve accessibility and efficacy of gene therapies in the CNS
- Discussing the role that gene therapy will play in the future of CNS disease management and potential cures
- Using Genetic Populations to Validate Clinical Success Before Applying to Larger Patient Populations
